ABLE recommends setting up of Rs 5,000 cr biomanufacturing fund
Most therapy solutions in these disease areas are provided by biopharmaceuticals
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Market
Strengthening presence in established markets drives M&A activity
The pharmaceutical sector recorded 36 M&A transactions in May 2012, against the previous six months’ average of 54.8…
Pharmexcil to take part in CPhI Worldwide in Madrid
It will also support the Brand India Pharma Campaign
DIA to conduct workshop on imaging in clinical trials
Workshop to be conducted in collaboration with Image Core Lab and Teleradiology Solutions
Piramal Healthcare to acquire US-based DRG for Rs 3,400 cr
Piramal Healthcare has decided to enter the healthcare information segment by acquiring 100 per cent stake in US-based firm…
Moving with the market
Viveka Roychowdhury reports on the successful right-sizing of strategies by both pharma MNCs and their Indian counterparts Spencer…
DBT calls for proposals on low cost health care technologies, products
Diagnostics for infectious disease and allergy, biomedical devices and vaccines are key focus areas; submissions close on June 30,…
Health ministers to debate binding convention on R&D
MSF urges the ministers at the 65th World Health Assembly to seize this unique opportunity The world’s health ministers, gathering…
Venus Remedies bags patent from CIPRO, SA
The company’s research centre is working on drugs and technologies to treat serious fatal mixed multi-bacterial infectious…
Ind-Swift, Wockhardt UK launch atorvastatin tabs in UK
The first day launch of atorvastatin in collaboration with its marketing partner Wockhardt UK is a significant achievement for…